Onshow - Thanks for the time and effort in undertaking this exercise and thanks to Geoff and company for providing responses
I also note the responses to questions 3 and 12 re: exclusivity and buy-Out!.
The thought of what the share price could do if one IVD company went for exclusivity or a buyout of ADO is staggering.
I'm not sure that any buyout would truly value ADO at its long term potential within and outside the medical field, but it would certainly be interesting to see if any company did follow that path would the offer would be.
As for exclusivity, if it was for the IVD side of things where ADO was looking for royalties of up to $150m, one exclusivity signing here could see the value of deal being worth in the dollars and not cents.
Patience fellow holders - I'm ok losing a half cent or cent per share over the coming months, when one has a look at the potential gains to be made.
And I'm still topping up.
Seb
- Forums
- ASX - By Stock
- ADO
- question and answers
ADO
anteotech ltd
Add to My Watchlist
0.00%
!
1.3¢

question and answers, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.16M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $10.88K | 843.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 246504 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 2711219 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1901789 | 0.012 |
9 | 2353674 | 0.011 |
8 | 3709000 | 0.010 |
10 | 1803777 | 0.009 |
10 | 3571875 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 2711219 | 8 |
0.015 | 4089116 | 12 |
0.016 | 1475197 | 3 |
0.017 | 218695 | 4 |
0.018 | 499000 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online